Despite another positive weekly performance by the S&P 500 (SPX) this past trading week, it didn’t really feel that way based on the declines in the final 2 trading sessions of the week, and especially with the declines in the large-cap/Growth areas of the market and Nasdaq (COMPQ). When it was all said and done, the meager gains in the…
Ignore The Headlines; Absorb The Opportunity
A financial market resource for the every-day investor and trader.
-
Weekly State of the Market: 9/24/2020
Seth Golden, , Research Reports, 0
Welcome to this week’s State of the Markets with Wayne Nelson and Seth Golden. Please click the following link to review the SOTM video. In this week’s...
-
Market Recovery Process Meets Resurgence Fears
Seth Golden, , Research Reports, 0
After retreating some 4.7% in the previous week, the S&P 500 (SPX) took back some of the consolidation. For...
-
Leuthold Group: Market Signals Increase Exposure
Seth Golden, , Research Reports, 0
Doug Ramsey Chief Investment Officer & Portfolio Manager: Doug is the Chief Investment Officer of The Leuthold Group, LLC, and...
-
Target’s 2017 Ends As 2018 Begins: Reviewing Results & Guidance
Seth Golden, , Research Reports, 0
Earlier this month, Target released its Q4 2017 results alongside 2018 guidance. The release brought with it selling pressure...
-
Markets Are On Knife’s Edge
Seth Golden, , Research Reports, 0
Welcome back Finom Group members! As we kick-off the monthly reporting cycle, we are recognizing gains for the first...
-
The Bear Market Survival Is Now Inflation Dependent
Seth Golden, , Research Reports, 0
The S&P 500 (SPX) rallied sharply this past week, gaining 6.45 percent. This is the second 6%+ weekly gain...
-
Consolidation Is Just As Big of A Must As New Highs
Seth Golden, , Research Reports, 0
Another week, another record high for the S&P 500 (SPX). This makes 20 record highs already in 2021. While...
-
Growth Vs. Vaccine
Seth Golden, , Research Reports, 0
The J.P. Morgan View Growth versus virus now, vaccine versus virus later —an update on a conflict and a...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00